Hernia-Prophylaxis in Acute Care Surgery H-PACS
H-PACS
Prophylactic Mesh Implantation in Patients Undergoing Requiring Emergency Laparatomy for the Prevention of Incisional Hernia:A Randomized Controlled Trial
1 other identifier
interventional
61
1 country
1
Brief Summary
Incisional hernia is a common complication in visceral surgery and varies between 11 and 26% in the general surgical population. Patients requiring emergency laparotomy are at high risk for the development of incisional hernia and fascial dehiscence. Among this population the incidence of incisional hernia in patients undergoing emergency surgery varies between 33-54%. Incisional hernias are associated with a high morbidity rate, such as intestinal incarceration, chronic discomfort, pain, and reoperation and typically require implantation of a synthetic mesh in a later second operation. Fascial dehiscence represents an acute form of dehiscence and has been observed in up to 24.1% and is associated with a mortality rate up to 44%. The gold standard for abdominal wall closure during elective and emergency operations is a running slowly absorbable suture. In the elective situation it has been shown that prophylactic mesh implantation in high risk patients reduced the incidence of incisional hernia significantly. The investigators and others have shown that mesh implantation in patients undergoing emergency laparotomy or in contaminated abdominal cavities are safe . With a randomized controlled trial the investigators now aim to compare the incidence of incisional hernia after prophylactic mesh implantation versus standard of care in patients requiring emergency laparotomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2017
CompletedFirst Submitted
Initial submission to the registry
March 20, 2017
CompletedFirst Posted
Study publicly available on registry
March 24, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 5, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 5, 2020
CompletedOctober 26, 2021
October 1, 2021
3.6 years
March 20, 2017
October 25, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Number of incidence of death
follow-up
up to 18 months
Number of patients with hernia free survival
follow-up
up to 18 months
Secondary Outcomes (8)
Number of patients with postoperative fascial dehiscence
30 days
Number of postoperative mortality
90 days
Number of surgical site infections postoperative
30 days
Number of postoperative intestinal fistulas
30 days
Number of small bowel obstructions
18 months
- +3 more secondary outcomes
Study Arms (2)
Mesh implantation
ACTIVE COMPARATORPrior to closure of the abdominal wall a mesh will be implanted in a standardized fashion
Single running suture of abdominal fascia
ACTIVE COMPARATORThe closure of the abdominal wall a Standard technique will be applied using a running suture
Interventions
Intra-abdominally Fixation
Intra-abdominal suture
Eligibility Criteria
You may qualify if:
- Patients undergoing emergency midline laparatomy
- Emergency laparoscopy with expected conversion to midline laparatomy
- Written informed consent
You may not qualify if:
- ASA ≥5
- Septic shock
- Pregnant women
- Prior mesh Implantation
- Known sensitivity for porcine material or Polysorbate 20
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dep. of Visceral and transplant surgery, Berne University Hospital
Bern, 3010, Switzerland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Guido Beldi, Prof. Dr.
Inselspital Berne
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 20, 2017
First Posted
March 24, 2017
Study Start
March 1, 2017
Primary Completion
October 5, 2020
Study Completion
October 5, 2020
Last Updated
October 26, 2021
Record last verified: 2021-10